Global Automated Cell Culture market [2017-2027] Middle East and Africa by Application

Growth Outlook

• The 2027] Middle East and Africa by Application portion of the Global Automated Cell Culture market [2017 market is on a steady long-term growth path. Segment value stands at roughly USD 719 Mn in 2026 and is projected to reach USD 752 Mn by 2027 — a gain of about 5% over the forecast period, translating to a CAGR in the mid-single digits.
• biopharmaceutical production segment accounted for the largest market share in 2019, this market is expected to reach USD 170. 90 Million in 2027 from USD 100.
• What the regional split looks like (2026): Biopharmaceutical Production leads, holding roughly 23% of segment value — the single largest regional share. Tissue Engineering & Regenerative Medicine is the second-largest contributor. Drug Screening and Development, Gene therapy, Stem Cell Research, Diagnostics, Toxicity testing and Others make up the remainder, in descending order.
• By 2027, Biopharmaceutical Production alone is expected to reach USD 171 Mn, with Drug Screening and Development at USD 130 Mn.

Market Dynamics

biopharmaceutical production segment accounted for the largest market share in 2019, this market is expected to reach USD 170.90 Million in 2027 from USD 100.00 Million in 2019. This market is projected to grow at a CAGR of 6.51% during the forecast period from 2020 - 2027. However, drug screening and development segment is the fastest growing market, which is expected to grow at a CAGR of 6.97% during the forecast period 2020 - 2027.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.